Delivery Order SPE2DB25D2207-SPE2DB25FQRVU
- Not listed
- The Defense Logistics Agency awarded a $5,966.66 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Tadliq 20 mg/5 ml Suspension in 150 ml quantities, with an ultimate completion date of August 5, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for pharmaceutical products to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $22,892.70 to AmerisourceBergen Drug Corp for the supply of Tadliq 20 mg/5 ml suspension (150 ml) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office is headquartered. This delivery order is a child contract issued under...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,569.42, is for the supply of TADLIQ 20 MG/5 ML SUSPENSION 150ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 29, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,219.11 to Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract is for the provision of TADLIQ 20 MG/5 ML SUSPENSION 150ML, a pharmaceutical product, with a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,814.63 firm fixed-price delivery order is for the provision of TADLIQ 20 MG/5 ML SUSPENSION 150ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 13, 2025. There is no set-aside designation associated...
- The Defense Logistics Agency awarded a $13,963.18 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Talvey 40 mg/ml vials. This firm fixed-price, competitively awarded contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. The delivery order carries no set-aside designation and represents a relatively small-value transaction within the contractor's broader federal...
- The Defense Logistics Agency awarded a $10,218.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 capsules of Tavneos 10 mg, a pharmaceutical product for federal medical supply needs. This non-competitive delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a $13,083.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TIVDAK 40 mg vials, with an ultimate completion date of June 24, 2025. This non-set-aside delivery order represents a single pharmaceutical procurement under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,557.11 to AmerisourceBergen Drug Corp on September 18, 2025, for TURQOZ-28 tablets in a 28-unit package. This firm fixed price delivery order, which must be completed by September 19, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a non-set-aside, competitive basis, reflecting the contractor's established capability to meet...
- The Defense Logistics Agency awarded a $16.9K delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Datroway 100 mg vials, with completion targeted for October 20, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The vendor, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal...
- SPE2DB25D2207Indefinite Delivery Contract
- SPE2DB25D2207-SPE2DB25FQRVUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tadliq 20 mg/5 mL suspension (150 mL) on September 24, 2025, with a ceiling value of $8,809.69. This non-set-aside delivery order is scheduled for completion by September 25, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes firm fixed price pricing and represents a child award under a larger contract vehicle. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and other government healthcare systems worldwide. The company has demonstrated consistent capability to fulfill federal medical supply requirements through competitive procurement processes across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and related medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 9/24/25 |